Reply to "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'".
2021
-
Correction
-
Source
-
Cite
-
Save
7
References
0
Citations
NaN
KQI